A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)

clinical trial
MedicalStudy clinical_trial Q64804500
Press Enter · cited answer in seconds

Summary

A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS) is a clinical trial[1].

Key Facts

  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS) is in the country of Italy[2].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s instance of is recorded as clinical trial[3].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s start time is recorded as +2018-03-26T00:00:00Z[4].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s end time is recorded as +2019-01-11T00:00:00Z[5].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s main subject is recorded as sclerosis[6].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s main subject is recorded as multiple sclerosis[7].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s number of participants is recorded as {'unit': '1', 'amount': '+7'}[8].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s title is recorded as Evaluation of clINical reCovery After a Relapse: a Pilot Study assEssing the Neuronal Effects of D-Aspartate in RR-MS Subjects Treated With IntErferon Beta 1a 44 mcg TIW (INCREASE)[9].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s short name is recorded as INCREASE[10].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s ClinicalTrials.gov ID is recorded as NCT03387046[12].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+55'}[13].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s research intervention is recorded as methylprednisolone[14].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s research intervention is recorded as methylprednisolone hemisuccinate[15].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s research intervention is recorded as prednisolone[16].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s research intervention is recorded as prednisolone acetate[17].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s research intervention is recorded as prednisolone 21-phosphate[18].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s clinical trial phase is recorded as phase II clinical trial[19].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s research site is recorded as Azienda Ospedaliera di Padova[20].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s research site is recorded as Regional Hospital San Camillo Forlanini[21].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s research site is recorded as Agostino Gemelli University Polyclinic[22].
  • A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)'s study type is recorded as interventional study[23].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.
  19. [20] ↑ . wikidata.org.
  20. [21] ↑ . wikidata.org.
  21. [22] ↑ . wikidata.org.
  22. [23] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS). Retrieved May 3, 2026, from https://4ort.xyz/entity/a-pilot-study-in-subjects-with-relapsing-remitting-multiple-sclerosis-rr-ms-
MLA “A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS).” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/a-pilot-study-in-subjects-with-relapsing-remitting-multiple-sclerosis-rr-ms-.
BibTeX @misc{4ortxyz_a-pilot-study-in-subjects-with-relapsing-remitting-multiple-sclerosis-rr-ms-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)}}, year = {2026}, url = {https://4ort.xyz/entity/a-pilot-study-in-subjects-with-relapsing-remitting-multiple-sclerosis-rr-ms-}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): A Pilot Study in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS) — https://4ort.xyz/entity/a-pilot-study-in-subjects-with-relapsing-remitting-multiple-sclerosis-rr-ms- (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/a-pilot-study-in-subjects-with-relapsing-remitting-multiple-sclerosis-rr-ms- · Last refreshed: